Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014

Holomic is expanding its portfolio of rapid test solutions with the debut of its fluorescent immunoassay reader, the HRDR-300, at the American Association of Clinical Chemistry (AACC) meeting in Chicago, July 28-31, 2014.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Holomic will showcase the fluorescent HRDR-300 and other rapid test solutions at the AACC meeting in Chicago at booth #2043, July 29-31, 2014.

Los Angeles, CA (PRWEB) July 22, 2014

Holomic is expanding its portfolio of rapid test solutions with the debut of its fluorescent immunoassay reader, the HRDR-300, at the American Association of Clinical Chemistry (AACC) meeting in Chicago, July 28-31, 2014. Available in both portable Smartphone based or bench top versions, the HRDR-300 is a highly sensitive, low-cost fluorescent reader that uses patent pending technology to analyze fluorescent lateral flow immunoassays with high sensitivity and accuracy.

The HRDR-300 provides a comprehensive rapid test solution to manufacturers and end-users of fluorescent tests. For manufacturers, the HRDR-300 fluorescent reader can be used as a universal reader for tests of all formats and sizes and at prices that compete with similar bench top instruments in the market. Coupled with Holomic’s ‘Test Developer', rapid test vendors can obtain deeper insight into the performance of their tests and create reader calibration files for download by end users.

Other features include test and lot number identification as well as test and patient data retrieval from bar/QR codes. The reader has lab and field applications with connectivity to a secure CLOUD server for remote data access and analytics as well as EHR and LIS integration.

The HRDR-300 is a key addition to Holomics portfolio of rapid test solutions that already comprises of chromatographic readers and software and data management solutions. With a suite of reader products, the company has developed customized reader solutions for the clinic/home-use, global health and lateral flow immunoassay manufacturing markets. The HRDR-300 is compliant with ISO13485 and is registered with the FDA as a Class 1 medical device. Visit http://www.holomic.com for more information.

Holomic will showcase the HRDR-300 and other rapid test solutions at the AACC meeting in Chicago at booth #2043, July 29-31, 2014. Holomic will also exhibit the same at Medica in Dusseldorf, November 12-15, 2014. Contact Ketaki Sood, Director of Product Marketing, ketaki(at)holomic(dot)com, 310.443.2070, http://www.holomic.com.

The HRDR-300 is available for sale globally. In the US, it is available for Research Use Only. Not for use in diagnostic procedures.


Contact